1 |
Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biologicaql actions. Endocr Rev 1995: 16:3-34
|
2 |
Miyao M, Hosoi T, Inoue S, Hoshino S, Shiraki M, Orimo H, et al. Polymorphism of insulin-like growth factor I gene and bone mineral density. Calcif Tissue Int 1998;63:306-11
DOI
|
3 |
Jernstrom H, Chu W, Vesprini D, Tao Y, Majeed N, Deal C, et al. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: Implications for premenopausal breast cancer risk. Mol Genet Metabol 2001;72:144-54
DOI
ScienceOn
|
4 |
Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birth weight. Lancet 2002;359:1036-7
DOI
ScienceOn
|
5 |
Jiang DK, Shen H, Li MX, Jiang C, Yang N, Zhu J, et al. No major effect of the insulin-like growth factor I gene on bone mineral density in premenopausal Chinese women. Bone 2005;36:694-9
DOI
ScienceOn
|
6 |
Rietveld I, Janssen JAMJL, van Rossum EFC, Houwing-Duistermaat JJ, Rivadeneira F, Hofman A, et al. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clin Endocrinol 2004;61:195-203
DOI
ScienceOn
|
7 |
Rietveld I, Janssen JAMJL, Hofman A, Pols HAP, van Duijn CM, Lamberts SWJ. A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. Eur J Endocrinol 2003;148:171-5
DOI
ScienceOn
|
8 |
Yang H, Adamo ML, Koval AP, McGuiness MC, Ben-Hur H, Yang Y, et al. Alternative leader sequences in insulin- like growth factor I mRNAs modulate translational efficiency and encode multiple signal peptides. Endocrinology 1995;9:1380-95
DOI
|
9 |
Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996;76:1005-26
DOI
|
10 |
Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, et al. Serum levels of insulin-like factor(IGF)-binding protein-3(IGFBP-3) in healthy infants, children, and adolscents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-42
DOI
|
11 |
te Velde SJ, van Rossum EF, Voorhoeve PG, Twisk JW, van de Waal AD, Stehouwer CD, et al. An IGF-I promotor polymorphism modifies the relationships between birth weight and risk factors for cardiovascular disease and diabetes at age 36. BMC Endocrine Disordes 2005;5:5-13
DOI
ScienceOn
|
12 |
Arends N, Hohnston L, Hokken-Koelega A, van Duijn C, de Ridder M, Savage M, et al. Polymorphism in the IGF-I gene: Clinical relevance for short children born small for gestational age(SGA). J Clin Endocrinol Metab 2002;87: 2720-4
DOI
ScienceOn
|
13 |
Adamo ML. Regulation of insulin-like growth factor I gene expression. Implications for normal and pathological growth. Diabetes Rev 1995;3:2-27
|
14 |
Foyt HL, LeRoith D, Roberts Jr CT. Differential association of insulin-like growth factor I mRNA variants with polysomes in vivo. J Biol Chem 1991;266:7300-5
|
15 |
Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, et al. Association between serum insulin-like growth factor-I(IGF-I) and a simple sequence repeat in IGF-I gene: Implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 1998;83:2286-90
DOI
|
16 |
Harrela M, Koinstinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1 and IGFBP-3. J Clin Invest 1996;98:2612-15
DOI
ScienceOn
|
17 |
Kim JG, Roh KR, Lee JY. The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism, and bone mineral density in postmenopausal women in Korea. Am J Obstet Gynecol 2002;186: 345-50
DOI
ScienceOn
|
18 |
Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, et al. A putative fuctional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 2002;51:2313-16
DOI
ScienceOn
|
19 |
Day INM. Insulin-like growth factor-I genotype and birth weight. Lancet 2002;360:945
|
20 |
Brissenden JE, Ullrich A, Francke U. Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor. Nature 1984;310:781-4
DOI
ScienceOn
|
21 |
Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J. Growth hormone(GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994;15:369-90
DOI
|
22 |
Yu H, Li BDL, Smith M, Shi R, Berkel HJ, Kato I. Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res Treat 2001;70:117-22
DOI
ScienceOn
|
23 |
Kao PC, Matheny APJ, Lang CA. Insulin-like growth factor-I comparisons in healthy twin children. J Clin Endocrinol Metab 1994;78:310-2
DOI
|
24 |
Laron Z. Natural history of the classical form of primary growth hormone(GH) resistance(Laron syndrome). J Pediatr Endocrinol Metab 1999;12(Suppl 1):231-49
|
25 |
Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, et al. A polymorphism in the gene for IGF-I:functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50;637-42
DOI
ScienceOn
|
26 |
Langford KS, Miell JP. The insulin-like growth factor-I/binding protein axis: physiology, pathophysiology and therapeutic manipulation. Eur J Clin Invest 1993;23:503-16
DOI
ScienceOn
|
27 |
Takacs I, Koller Dl, Peacock M, Christian JC, Hui SL, Conneally PM, et al. Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus. J Clin Endocrinol Metab 1999; 84:4467-71
DOI
|
28 |
Allen NE, Davey GK, Key TJ, Zhang S, Narod SA. Serum insulin-like growth factor I(IGF-I) concentration in men is not associated with cytosine-adenine repeat polymorphism of the IGF-I gene. Cancer Epidemiol Biomarkers Prev 2002;11:319-20
|
29 |
Rotwein P. Sturucture, evolution, expression and regulation of insulin-like growth factors I and II. Growth factors 1991;5:3-18
DOI
|
30 |
Mittanck DW, Kim SW, Rotwein P. Essential promoter elments are located within the 5' untranslated region of human insulin-like growth factor-I exon I. Mol Cell Endocrinol 1997;126:153-63
DOI
ScienceOn
|
31 |
Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003;349:1139-47
DOI
ScienceOn
|